AAAAAA

   
Results: 1-12 |
Results: 12
THE EFFECT OF IMMUNOTOXINS DIRECTED AGAINST CD80 AND CD86 ON PRIMARY T-CELL ALLORESPONSES
Authors: OTTEN HG VOOIJS WC VANDERGOUW L DEBOER M DEGAST GC
Citation: Hg. Otten et al., THE EFFECT OF IMMUNOTOXINS DIRECTED AGAINST CD80 AND CD86 ON PRIMARY T-CELL ALLORESPONSES, Tissue antigens, 52(3), 1998, pp. 270-274
PREVENTION OF PRIMARY T-CELL RESPONSES BY IMMUNOTOXINS DIRECTED AGAINST CD80 AND CD86
Authors: OTTEN HG VOOIJS WC VANDERGOUW AP DEBOER M DEGAST GC
Citation: Hg. Otten et al., PREVENTION OF PRIMARY T-CELL RESPONSES BY IMMUNOTOXINS DIRECTED AGAINST CD80 AND CD86, Transplantation proceedings, 29(1-2), 1997, pp. 1034-1035
B7-1 (CD80) AS TARGET FOR IMMUNOTOXIN THERAPY FOR HODGKINS-DISEASE
Authors: VOOIJS WC OTTEN HG VANVLIET M VANDIJK AJG DEWEGER RA DEBOER M BOHLEN H BOLOGNESI A POLITO L DEGAST GC
Citation: Wc. Vooijs et al., B7-1 (CD80) AS TARGET FOR IMMUNOTOXIN THERAPY FOR HODGKINS-DISEASE, British Journal of Cancer, 76(9), 1997, pp. 1163-1169
EFFICACY AND TOXICITY OF PLASMA-CELL-REACTIVE MONOCLONAL-ANTIBODIES B-B2 AND B-B4 AND THEIR IMMUNOTOXINS
Authors: VOOIJS WC POST J WIJDENES J SCHUURMAN HJ BOLOGNESI A POLITO L STIRPE F BAST EJEG DEGAST GC
Citation: Wc. Vooijs et al., EFFICACY AND TOXICITY OF PLASMA-CELL-REACTIVE MONOCLONAL-ANTIBODIES B-B2 AND B-B4 AND THEIR IMMUNOTOXINS, Cancer immunology and immunotherapy, 42(6), 1996, pp. 319-328
THE MONOCYTIC CELL-LINE I937 DISPLAYS TYPICAL B-CELL CHARACTERISTICS
Authors: REISCHL IG POLLABAUER EM PEIRITSCH S SCHLAGER S GLADSTONE P VOOIJS WC WOISETSCHLAGER M MUDDE GC
Citation: Ig. Reischl et al., THE MONOCYTIC CELL-LINE I937 DISPLAYS TYPICAL B-CELL CHARACTERISTICS, Immunology letters, 49(1-2), 1996, pp. 127-131
A PLASMACYTE SELECTIVE MONOCLONAL-ANTIBODY (B-B4) RECOGNIZES SYNDECAN-1
Authors: WIJDENES J VOOIJS WC CLEMENT C POST J MORARD F VITA N LAURENT P SUN RX KLEIN B DORE JM
Citation: J. Wijdenes et al., A PLASMACYTE SELECTIVE MONOCLONAL-ANTIBODY (B-B4) RECOGNIZES SYNDECAN-1, British Journal of Haematology, 94(2), 1996, pp. 318-323
IMMUNOTOXIN AND CD3 CONTAINING BISPECIFIC ANTIBODY-DIRECTED AGAINST THE SAME ANTIGEN (SYNDECAN-I) ARE EQUALLY EFFECTIVE IN-VITRO AGAINST PLASMA-CELL LINES
Authors: VOOIJS WC POST J GLENNIE M WIJDENES J STIRPE F BAST EJEG DEGAST GC
Citation: Wc. Vooijs et al., IMMUNOTOXIN AND CD3 CONTAINING BISPECIFIC ANTIBODY-DIRECTED AGAINST THE SAME ANTIGEN (SYNDECAN-I) ARE EQUALLY EFFECTIVE IN-VITRO AGAINST PLASMA-CELL LINES, Blood, 88(10), 1996, pp. 3616-3616
ENHANCED CYTOTOXICITY AGAINST REED-STERNBERG CELL-LINES BY THE COMBINATION OF ANTI-B7-1 (ALPHA-CD80) AND ANTI-B7-2 (ALPHA-CD86) IMMUNOTOXINS
Authors: VOOIJS WC OTTEN HG VANHATTUM AH VANVLIET M DEWEGER RA DEBOER M STIRPE F DEGAST GC
Citation: Wc. Vooijs et al., ENHANCED CYTOTOXICITY AGAINST REED-STERNBERG CELL-LINES BY THE COMBINATION OF ANTI-B7-1 (ALPHA-CD80) AND ANTI-B7-2 (ALPHA-CD86) IMMUNOTOXINS, Blood, 88(10), 1996, pp. 338-338
PREVENTION OF PRIMARY T-CELL ALLORESPONSES BY IMMUNOTOXINS DIRECTED AGAINST CD80 AND CD86
Authors: OTTEN HG VOOIJS WC VANDERGOUW AP DEBOER M DEGAST GC
Citation: Hg. Otten et al., PREVENTION OF PRIMARY T-CELL ALLORESPONSES BY IMMUNOTOXINS DIRECTED AGAINST CD80 AND CD86, Blood, 88(10), 1996, pp. 985-985
SPECIFIC INTERFERON-GAMMA PRODUCING CD4(-CELLS AFTER AUTOLOGOUS EBV-BSTIMULATION - THE NECESSITY OF RESTIMULATION() AND CD8(+) T)
Authors: VOOIJS WC NOOTEBOS MG WERNERT H DEGAST GC
Citation: Wc. Vooijs et al., SPECIFIC INTERFERON-GAMMA PRODUCING CD4(-CELLS AFTER AUTOLOGOUS EBV-BSTIMULATION - THE NECESSITY OF RESTIMULATION() AND CD8(+) T), Scandinavian journal of immunology, 42(6), 1995, pp. 591-597
EVALUATION OF B7-1 AND B7-2 IMMUNOTOXINS AS POTENTIAL THERAPY FOR HODGKINS-DISEASE
Authors: VOOIJS WC POST J OTTEN HG DEWEGER RA DEBOER M DEGAST GC
Citation: Wc. Vooijs et al., EVALUATION OF B7-1 AND B7-2 IMMUNOTOXINS AS POTENTIAL THERAPY FOR HODGKINS-DISEASE, Blood, 86(10), 1995, pp. 3291-3291
EVALUATION OF CD38 AS TARGET FOR IMMUNOTHERAPY IN MULTIPLE-MYELOMA
Authors: VOOIJS WC SCHUURMAN HJ BAST EJEG DEGAST GC
Citation: Wc. Vooijs et al., EVALUATION OF CD38 AS TARGET FOR IMMUNOTHERAPY IN MULTIPLE-MYELOMA, Blood, 85(8), 1995, pp. 2282-2283
Risultati: 1-12 |